Preclinical data demonstrated durable immune responses and tumor growth inhibition with Mural's IL-18 variants, reinforcing ...

WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE ... Results from two Phase 3 trials evaluating the effect on patient-reported outcomes in patients with chronic refractory gout treated with SEL-212.

Judge postpones all proceedings in Donald Trump’s hush-money case through 19 November.   17:09 If Donald Trump ...

Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeekHigh Quality Obesity Management by Targeting the CRF2 Receptor: Enhanced Fat Loss with Lean Mass IncreaseImproved .

Some may say we are in a renaissance of video game adaptations as we've been treated to The Super Mario Bros. Movie, another ...

Mural is also evaluating a less-frequent intravenous (LFIV) dose of nemvaleukin in patients with cutaneous melanoma in ...

A meme purports to outline what it calls "The Trump-Vance Project 2025 Plan," although both U.S. President-elect Trump and ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

An invitation for study participation was highlighted in a weekly email-newsletter sent by the race host organisation (Boston Athletic Association) for 4 weeks pre-race and via posters at the ... 95% ...

Certain GLP-1 medications, like Ozempic, are only FDA-approved for type 2 diabetes, and others, like Wegovy, are approved for ...

Real-world data showed mean BMI decrease of 12.8% in adult patients with acquired hypothalamic obesity (N=8) at three months on setmelanotide ...

Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Al ...